In older adults without CVD, treating 100 persons with statins for 2.5 y prevents 1 MACE

Lionel S Lim

doi:10.7326/ACPJ202104200-039

In older adults without CVD, treating 100 persons with statins for 2.5 y prevents 1 MACE

Ann Intern Med. 2021 Apr;174(4):JC39. doi: 10.7326/ACPJ202104200-039. Epub 2021 Apr 6.

Author

Lionel S Lim¹

Affiliation

¹ VA Bedford Healthcare System, Bedford, Massachusetts, USA (L.S.L.).

PMID: 33819067
DOI: 10.7326/ACPJ202104200-039

Abstract

Yourman LC, Cenzer IS, Boscardin WJ, et al. Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis. JAMA Intern Med. 2021;181:179-85. 33196766.

Keywords: Cardiovascular diseases; Hydroxymethylglutaryl-CoA reductase inhibitors.

Publication types

Comment

MeSH terms

Aged
Cardiovascular Diseases* / prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Middle Aged
Primary Prevention

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors